Chimeric Antigen Receptor-Modified T Cells for Breast Cancer
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: BIOLOGICAL: HER-2-targeting CAR T Cells infusion
Sponsor: Fuda Cancer Hospital, Guangzhou